c-Rel dependant Chk2 signalling regulates the DNA damage response limiting hepatocarcinogenesis

Hepatology. doi:10.1111/hep.32781

Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma

Liver Cancer. doi: 10.1159/000519867

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification

Gut. doi: 10.1136/gutjnl-2021-325918

Novel Cellular Therapies for Hepatocellular Carcinoma

Cancers (Basel). doi: 10.3390/cancers14030504

Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy

Cell Death & Disease.  doi: 10.1038/s41419-022-04580-8

Neutrophils as potential therapeutic targets in hepatocellular carcinoma

Nature Reviews Gastroenterol Hepatology. doi: 10.1038/s41575-021-00568-5